D OES H ORIZON 2020 ADDRESS THE NEEDS OF BIOMEDICAL AND HEALTH RESEARCH ? ‘H IGH - LEVEL MEETING TO BRAINSTORM WITH KEY DRIVERS IN EU HEALTH RESEARCH POLICY ’ E UROPEAN P ARLIAMENT · 24 J ANUARY 2012 O RGANIZED BY M ARIA DA G RAÇA C ARVALHO MEP I Prof Karin Sipido, Vice-President, Alliance for Biomedical Research in Europe
Horizon 2020 concept Health research is part of the 3 priorities excellent science industrial leadership societal challenges Boosting the innovation chain addresses the need for better health research and care
need for long term commitment.. but innovation chain is long in health research
4 Health ● Understanding the determinants of health (including environmental and climate related factors), improving health promotion and disease prevention; ● Developing effective screening programmes and improving the assessment of disease susceptibility ● Improving surveillance and preparedness ● Understanding disease ● Developing better preventive vaccines ● Improving diagnosis ● Using in-silico medicine for improving disease management and prediction ● Treating disease Priorities 1/2: The EC proposes an ambitious program but budget drops from 12 to 10% of total budget..
yet EU health research funding is not competitive
Fragmentation of efforts in funding Research in valve & tissue engineeringDG R&D ICT approaches to support surgeryDG INFSO Regulation of new valve technologyDG SANCO Clinical survey - registries???
Key stakeholders need direct input and participation
.. need for a European Health Research Council.. a consolidated and interconnected research funding platform for a coordinated response to the health challenges ahead providing expert advice to drive policy-making The Biomed Alliance has set up a Working Group
Biomed Alliance Working Group tasks enlisting participation of key scientists and policy advisors - done set up the roadmap for a Health Council organize a broad stakeholder consultation present a proposal for a EuHRC
WWW. BIOMEDEUROPE. ORG ‘H IGH - LEVEL MEETING TO BRAINSTORM WITH KEY DRIVERS IN EU HEALTH RESEARCH POLICY ’ E UROPEAN P ARLIAMENT · 24 J ANUARY 2012 O RGANIZED BY M ARIA DA G RAÇA C ARVALHO MEP I Prof Karin Sipido, Vice-President, Alliance for Biomedical Research in Europe